Outcomes Following Radiation Therapy for Head and Neck Cancer of a High Volume Center Versus Low Volume Center
A.O. Naghavi, J.J. Caudell(Moffitt Cancer Center), T. Ström, A. Boidi Trotti(University of Tampa), Nikhil G. Rao
International Journal of Radiation Oncology*Biology*Physics
September 1, 2014
Cited by 1
Related Papers
Proinflammatory Role for let-7 MicroRNAS in Experimental Asthma
|Journal of Biological Chemistry|2010|240
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline
|Journal of Clinical Oncology|2020|221
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
|International Journal of Radiation Oncology*Biology*Physics|2023|18
A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary report
|Annals of Oncology|2019|5
NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Combination With Anti-PD-1 Therapy: A Phase I Study
|International Journal of Radiation Oncology*Biology*Physics|2020|4